Lantern Pharma Inc Aktie News
3,42 $
2,56 %
vorgestern
Nasdaq,
16. Januar, 22:00 Uhr
tracken
Lantern Pharma Inc Aktie News
Neutral
Business Wire
●
6 Tage alt
DALLAS--(BUSINESS WIRE)--A.I. center of excellence - Lantern Pharma.
Neutral
Business Wire
●
etwa 2 Monate alt
DALLAS--(BUSINESS WIRE)--LP-184 Clinical Insights, KOL Webinar & Future Plans.
Positiv
Finbold
●
etwa 2 Monate alt
Palantir Technologies (NASDAQ: PLTR) has grown into a dominant force in AI-driven data analytics, securing lucrative government contracts and expanding its mission-critical intelligence business.
Neutral
Seeking Alpha
●
etwa 2 Monate alt
Lantern Pharma Inc. ( LTRN ) Discusses LP-184 Phase 1a Clinical Results and Implications for DNA Damage Repair-Deficient Tumors November 20, 2025 4:30 PM EST Company Participants Panna Sharma - President, CEO & Director Kishor Bhatia - Chief Scientific Officer & Scientific Consultant Reggie Ewesuedo Conference Call Participants Igor Astsaturov Presentation Panna Sharma President, CEO & Director...
Neutral
Seeking Alpha
●
2 Monate alt
Lantern Pharma Inc. ( LTRN ) Q3 2025 Earnings Call November 13, 2025 9:00 AM EST Company Participants Panna Sharma - President, CEO & Director David Margrave - CFO & Secretary Presentation Operator Good morning, and welcome to our third quarter 2025 earnings call. As a reminder, this call is being recorded [Operator Instructions].
Neutral
Business Wire
●
2 Monate alt
DALLAS--(BUSINESS WIRE)--Q3 Press Release - BTM.
Neutral
Business Wire
●
2 Monate alt
DALLAS--(BUSINESS WIRE)--Lantern Pharma to Report Third Quarter 2025 Operating & Financial Results on November 13th, 2025 at 9:00 a.m. ET.
Neutral
Business Wire
●
3 Monate alt
DALLAS--(BUSINESS WIRE)--Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
